Latest Sobi News & Updates

See the latest news and media coverage for Sobi. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sobi

Biopharmaceutical company focused on rare diseases

sobi.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
2,300–5,000

Last updated

Latest news about Sobi

In short: Sobi reported strong 2025 growth with 24% Q1 revenue increases and advanced its rare disease pipeline through the $1.5 billion acquisition of Arthrosi.

Company announcements

Sobi

Sobi shows Tryngolza reduces pancreatitis risk

Pooled Phase 3 CORE/Core2 analysis of 455 sHTG patients showed 85% reduction in acute pancreatitis and 66% triglyceride reduction at six months; EMA validation and FDA priority review ongoing.

Sobi

Sobi welcomes two new board members

Åsa Riisberg and Mikael Dolsten were elected at the Annual General Meeting on 6 May 2026 and will strengthen governance and long-term strategy.

Unlock all announcements with a

Media coverage

Dagens industri

Sobi reports positive study results from growth leap

Sobi states that a drug candidate against gout has shown positive study results and achieved the primary endpoint. "We view these very positively..."

Unlock all articles with a

Never miss news about Sobi

Track Sobi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Sobi competitors & trending companies

Browse news for competitors to Sobi and other trending companies.